Home > Balance Sheet > CIPLA

CIPLA
Total Non-Current Liabilities

    Back to Balance Sheet
CIPLA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
COMMUNITY POLL
for CIPLA
Please provide your vote to see the results

CIPLA Last 5 Year Total Non-Current Liabilities History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Total Non-Current Liabilities ₹-31 Cr₹82 Cr₹184 Cr₹622 Cr₹1,660 Cr

What is the latest Total Non-Current Liabilities ratio of CIPLA ?

The latest Total Non-Current Liabilities ratio of CIPLA is ₹-31 Cr based on Mar2025 Consolidated results.
Year Total Non-Current Liabilities
Mar2025₹-31 Cr
Mar2024₹82 Cr
Mar2023₹184 Cr
Mar2022₹622 Cr
Mar2021₹1,660 Cr

How is Total Non-Current Liabilities of CIPLA Trending?

Years Total Non-Current Liabilities % Change
Mar2025 ₹-31 Cr
Negative
Mar2024 ₹82 Cr
-55.36
Mar2023 ₹184 Cr
-70.48
Mar2022 ₹622 Cr
-62.55
Mar2021 ₹1,660 Cr -

Compare Total Non-Current Liabilities of peers of CIPLA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CIPLA ₹104,589.9 Cr 5.4% 3.1% -13.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹388,680.0 Cr -2.9% -8.9% -3.7% Stock Analytics
DIVIS LABORATORIES ₹168,817.0 Cr 1.2% 4.2% 8.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹139,297.0 Cr -1.7% -3.6% 27.4% Stock Analytics
DR REDDYS LABORATORIES ₹109,828.0 Cr 6.8% 1.3% 13.2% Stock Analytics
MANKIND PHARMA ₹93,582.0 Cr 5.8% 13.4% -11.3% Stock Analytics


CIPLA Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CIPLA

5.4%

3.1%

-13.6%

SENSEX

-2.3%

3.3%

-2.4%


You may also like the below Video Courses